Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Published Date: 17 Feb 2023

Antibiotic use linked to SJ syndrome and toxic epidermal necrosis, sulfonamides are worst culprits in new study...

Read Full News

Latest News

Skin Cancer Location Potential Predictor of Poor Outcomes

Despite a higher incidence of poor outcomes with squamous cell carcinoma tumors on the scalp, it was the lip and temple that emerged as highest risk after adjustments for other factors.

Ultrafine Water Clusters Reduce Laser-Associated Erythema

A novel technology using nano-sized ultrafine water clusters is associated with significant reduction in the erythema that occurs post-laser treatment, new research shows.

A New Name for PCOS, the Most Common Cause Of Infertility

A disorder that affects 170 million women worldwide and is the leading cause of infertility known as polycystic ovary syndrome, ⁠or PCOS, is being renamed to improve...

Nail Unit SCC: Study Highlights Different Features

HPV and clinical features distinguish in situ vs invasive nail unit squamous cell carcinoma in a retrospective review.

Trump Says US FDA Commissioner Makary Is Out

U.S. FDA Commissioner Marty Makary resigned, President Donald Trump said on Tuesday, after weeks of clashing with top White House and health advisers and drawing scrutiny...

High-Risk SCC: New Expert Guidelines for Adjuvant Radiation

The guidelines provide a starting place for conducting studies and collecting data to confirm what experts currently are recommending in the absence of adequate data.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

Despite a higher incidence of poor outcomes with squamous cell carcinoma tumors on the scalp, it was the lip and temple that emerged as highest risk after adjustments for other factors.

A novel technology using nano-sized ultrafine water clusters is associated with significant reduction in the erythema that occurs post-laser treatment, new research shows.

A disorder that affects 170 million women worldwide and is the leading cause of infertility known as polycystic ovary syndrome, ⁠or PCOS, is being renamed to improve...

HPV and clinical features distinguish in situ vs invasive nail unit squamous cell carcinoma in a retrospective review.

U.S. FDA Commissioner Marty Makary resigned, President Donald Trump said on Tuesday, after weeks of clashing with top White House and health advisers and drawing scrutiny...

The guidelines provide a starting place for conducting studies and collecting data to confirm what experts currently are recommending in the absence of adequate data.

News All Time

White House Details Cause of Trump's Neck Redness

Photos from at least as far back as last week show visible redness on the president's neck

What Cream Is Trump Using on His Neck?

Does the President's annual physical report provide a clue?

Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study

Quiz Time: What Caused Trump's Neck Redness?

You passed medical training, now see if you can pass our weekly quiz

CDC Study Warns on Infection-Related Cancers After Organ Transplant

Kaposi sarcoma-associated herpesvirus testing is not routinely performed on donors or recipients

Sentinel Node Biopsy Improves Survival in Melanoma, Meta-Analysis Shows

"Our findings provide the best evidence available," researchers say

GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions

Retrospective study finds link between blockbuster drugs and longer survival

Bimekizumab Safety Holds Up in Long-Term Data

Pooled data from PsA and axSpA extension studies provide early reassurance

Hidradenitis Suppurativa Linked to Higher Risk of Self-Harm, Including Suicide

Twofold higher risk than general population, suicide more often preceded by episode of self-harm

'Potential Game Changer' for Psoriasis Gets Green Light From FDA

Oral IL-23 inhibitor icotrokinra achieved near-complete skin clearance in two-thirds of patients

FDA Withdraws Proposal for Tanning Bed Age Limit

Agency cites concerns raised in public comments; dermatologists emphasize risks for young people

FDA OKs First Drug for Liver Disease-Related Pruritus

Linerixibat approved for cholestatic itch in primary biliary cholangitis

Make the Diagnosis: From a Bone Marrow Transplant to a Huge Rash. What’s Your Diagnosis?

A 49-year-old man with a history of acute myeloid leukemia who received an allogeneic bone marrow transplant 2 weeks prior developed a widespread rash. Can you diagnose the patient?

EULAR Updates Its Guidance on Managing Behcet's Syndrome

Takes recent clinical trials, drug introductions into account

GLP-1 Drugs Pick Up Another Win, This Time in Psoriatic Arthritis

Adding tirzepatide to ixekizumab significantly improved primary and key secondary outcomes

Resistant Dermatomyositis Improves Quickly, Significantly With Combination Drug

Brepocitinib significantly boosts global, all secondary dermatomyositis scores in VALOR trial

Recommended News For You

According to JAMA, even four minutes a day of exercise can lower the risk of cancer.

New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

Kate Middleton Reaches Cancer Treatment Milestone

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

Recommended Articles For You

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development 

Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec 

The Latest Research on Wiskott Aldrich Syndrome  

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

2.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

3.

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

4.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

5.

Young adults who are obese are at risk for 17 different types of cancer in the future.

1.

The Latest Research on Wiskott Aldrich Syndrome 

2.

The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring

3.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

4.

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

5.

Introduction to Immune Thrombocytopenic Purpura

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

2.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

3.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

5.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot